间充质干细胞
医学
炎症
心肌病
帕金森病
肌萎缩侧索硬化
旁分泌信号
疾病
神经科学
免疫学
生物信息学
心力衰竭
病理
生物
内科学
受体
作者
Lamiaa A. Ahmed,Khaled F. Al‐Massri
出处
期刊:Current stem cell research & therapy
[Bentham Science]
日期:2021-03-03
卷期号:16 (7): 858-876
被引量:7
标识
DOI:10.2174/1574888x16666210303151237
摘要
Mesenchymal stem cells (MSCs) have shown promising therapeutic effects in a wide variety of medical conditions, including neurodegenerative disorders and cardiovascular diseases. Although preliminary research has emphasized the ability of MSCs to engraft at sites of injury, several studies have revealed that MSCs mediate their effects through the release of various paracrine factors and through their antioxidant, anti-inflammatory, immunomodulatory, and anti-apoptotic effects. The clinical implications of MSCs application are limited due to their low survival rate in conditions of inflammation, oxidative stress, and nutrient restriction in damaged areas. Furthermore, the function of isolated MSCs is usually affected by the patient’s health. Therefore, it is necessary to develop new methods to enhance the therapeutic efficacy of MSCs under pathophysiological conditions. This review provides an overview of the general properties of MSCs, their therapeutic potential in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease, as well as cardiovascular diseases such as myocardial infarction, diabetic cardiomyopathy, and dilated cardiomyopathy, and their related mechanisms. In addition, this review also discusses potential problems and side effects, as well as current and future directions for improvement of MSCs therapy and their implications and applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI